[ad_1]
The World Health Organization said Tuesday that there is obtained “potentially positive data” on some of the treatments for Covid-19 being tested “We have potentially positive data about to be published, but we need to see more data to be 100% sure that we can choose one treatment over the other,” said WHO spokeswoman Margaret Harris.
The head of the organization answered questions about the Solidarity Trial, a WHO initiative to compare unproven treatments in the most seriously ill patients on Covid-19. “We have some treatments that seem to be in very early studies, but limit the severity or duration of the disease“Confirmed.
However, Margaret Harris also notes that further analysis is needed and that, to date, “We have nothing that can kill or stop the virus”. The WHO spokeswoman had no comment on what these treatments were and promised to publish the preliminary results soon. But, according to Reuters, he will have indicated that there are “four to five” that are especially interesting to experts.
Remdesivir can now be used in Portugal. Will this drug be effective against Covid-19?
As the search for a vaccine to prevent infection with the new coronavirus continues, other drugs are drawing the attention of the scientific community. One of them is Remdesivir which, according to the North American laboratory Gilead Sciences, obtained “positive results” when administered to patients with Covid-19.
According to Gilead Sciences, “Patients who received the 10-day treatment achieved similar positive results in terms of clinical status as those who received treatment for five days.”
According to the company, this means that “the number of patients who could be treated with our current supply of Remdesivir could expand significantly”: “This is particularly important in the context of a pandemic, to help hospitals and health professionals to treat more patients who need urgent care ”, defends the laboratory.
